The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic.
Acute coronary syndrome
Arrhythmias
Cardiovascular disease
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Thrombosis; Heart failure
Journal
Cardiovascular drugs and therapy
ISSN: 1573-7241
Titre abrégé: Cardiovasc Drugs Ther
Pays: United States
ID NLM: 8712220
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
accepted:
07
06
2021
pubmed:
31
7
2021
medline:
17
3
2023
entrez:
30
7
2021
Statut:
ppublish
Résumé
COVID-19 pandemic has negatively impacted the management of patients with acute and chronic cardiovascular disease: acute coronary syndrome patients were often not timely reperfused, heart failure patients not adequately followed up and titrated, atrial arrhythmias not efficaciously treated and became chronic. New phenotypes of cardiovascular patients were more and more frequent during COVID-19 pandemic and are expected to be even more frequent in the next future in the new world shaped by the pandemic. We therefore aimed to briefly summarize the main changes in the phenotype of cardiovascular patients in the COVID-19 era, focusing on new clinical challenges and possible therapeutic options.
Identifiants
pubmed: 34328581
doi: 10.1007/s10557-021-07217-8
pii: 10.1007/s10557-021-07217-8
pmc: PMC8322635
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
341-351Informations de copyright
© 2021. The Author(s).
Références
De Rosa S, Spaccarotella C, Basso C, Calabrò MP, Curcio A, Filardi PP, Mancone M, Mercuro G, Muscoli S, Nodari S, Pedrinelli R, Sinagra G, Indolfi C. Indolfi Società Italiana di Cardiologia and the CCU Academy investigators group. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41:2083–8.
pubmed: 32412631
doi: 10.1093/eurheartj/ehaa409
Piccolo R, Bruzzese D, Mauro C, Aloia A, Baldi C, Boccalatte M, Bottiglieri G, Briguori C, Caiazzo G, Calabrò P, Cappelli-Bigazzi M, De Simone C, Di Lorenzo E, Golino P, Monda V, Perrotta R, Quaranta G, Russolillo E, Scherillo M, Tesorio T, Tuccillo B, Valva G, Villari B, Tarantini G, Varricchio A, Esposito G, Collaborators. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak. Circulation. 2020;141:2035–7.
pubmed: 32352318
pmcid: 7294593
doi: 10.1161/CIRCULATIONAHA.120.047457
Indolfi C, Spaccarotella C. The outbreak of COVID-19 in Italy: fighting the pandemic. JACC Case Rep. 2020; 2(9):1414–1418. Erratum in: JACC Case Rep. 2020;2:1656.
Molinari G, Brunetti ND, Nodari S, Molinari M, Spagna G, Ioakim M, Migliore G, Dattoli V, Di Cillo O. Impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease in Italy. Intern Emerg Med. 2020;2020:1–6.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531–8.
pubmed: 32161990
pmcid: 7087935
doi: 10.1007/s00392-020-01626-9
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846–8.
pubmed: 32125452
pmcid: 7080116
doi: 10.1007/s00134-020-05991-x
Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5:831–40.
pubmed: 32219363
doi: 10.1001/jamacardio.2020.1286
Madjid M, Safavi-Naeini P, Solomon S, et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5:831–40.
Azarkish M, Laleh far V, Eslami M, Mollazadeh R. Transient complete heart block in a patient with critical COVID-19. Eur Heart J. 2020;41:2131.
pubmed: 32285920
doi: 10.1093/eurheartj/ehaa307
ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance . (Last update: 10 June 2020).
Toniolo M, Negri F, Antonutti M, Masè M, Facchin D. Unpredictable fall of severe emergent cardiovascular diseases hospital admissions during the COVID-19 pandemic: experience of a single large center in northern Italy. J Am Heart Assoc. 2020;9:e017122.
pubmed: 32441548
pmcid: 7670496
doi: 10.1161/JAHA.120.017122
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. 2020;133:1025–31.
pubmed: 32044814
pmcid: 7147277
doi: 10.1097/CM9.0000000000000744
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811–8.
pubmed: 32219356
doi: 10.1001/jamacardio.2020.1017
Casale M, Dattilo G, Imbalzano E, Gigliotti De Fazio M, Morabito C, Mezzetti M, et al. The thromboembolism in COVID-19: the unsolved problem. Panminerva Med. 2020. https://doi.org/10.23736/S0031-0808.20.03999-3 .
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH, Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75:2950–73.
pubmed: 32311448
pmcid: 7164881
doi: 10.1016/j.jacc.2020.04.031
Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382:e38.
pubmed: 32268022
doi: 10.1056/NEJMc2007575
Zulfiqar A-A, Lorenzo-Villalba N, Hassler P, Andrès E. Immune thrombocytopenic purpura in a patient with Covid-19. N Engl J Med. 2020;382:e43.
pubmed: 32294340
doi: 10.1056/NEJMc2010472
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.
pubmed: 32173574
pmcid: 7194638
doi: 10.1016/j.ijid.2020.03.017
Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, Ibrahim H, Friedman GH, Thompson C, Alviar CL, Chadow HL, Fishman GI, Reynolds HR, Keller N, Hochman JS. ST-segment elevation in patients with Covid-19 - a case series. N Engl J Med. 2020;382:2478–80.
pubmed: 32302081
doi: 10.1056/NEJMc2009020
Meyer P, Degrauwe S, Delden CV, Ghadri J-R, Templin C. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. 2020;41:1860.
pubmed: 32285915
doi: 10.1093/eurheartj/ehaa306
Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratoryconfirmed influenza infection. N Engl J Med. 2018;378:345–53.
pubmed: 29365305
doi: 10.1056/NEJMoa1702090
Correale M, Tricarico L, Fortunato M, Dattilo G, Iacoviello M, Brunetti ND. Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches. Aging Clin Exp Res. 2021:1–6.
Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22:911–5.
pubmed: 32275347
doi: 10.1002/ejhf.1828
Mehra MR, Ruschitzka F. COVID-19 illness and heart failure: a missing link? JACC Heart Fail. 2020;8:512–4.
pubmed: 32360242
pmcid: 7151428
doi: 10.1016/j.jchf.2020.03.004
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.
pubmed: 32173574
pmcid: 7194638
doi: 10.1016/j.ijid.2020.03.017
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D’Arminio Monforte A, Ismail S, Kato H, Lapadula G, L’Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327–36.
pubmed: 32275812
doi: 10.1056/NEJMoa2007016
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A, Uriel N. COVID-19 and cardiovascular disease. Circulation. 2020;141:1648–55.
pubmed: 32200663
doi: 10.1161/CIRCULATIONAHA.120.046941
Zhang Y, Coats AJS, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22:941–56.
pubmed: 32463543
doi: 10.1002/ejhf.1915
Vaduganathan M, Vardeny O, Michel T, et al. Renin-angiotensin-aldosterone system. Inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653–9.
pubmed: 32227760
doi: 10.1056/NEJMsr2005760
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.
pubmed: 32171076
pmcid: 7270627
doi: 10.1016/S0140-6736(20)30566-3
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
pubmed: 31986264
pmcid: 7159299
doi: 10.1016/S0140-6736(20)30183-5
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 COVID-19. JAMA Cardiol. 2020;5:1–8.
pmcid: 7160750
doi: 10.1001/jamacardio.2020.1017
Stefanini G, et al. ST-elevation myocardial infarction in patients with COVID-19. Circulation. 2020;141:2113–6.
pubmed: 32352306
pmcid: 7302062
doi: 10.1161/CIRCULATIONAHA.120.047525
Murrone A, Colivicchi F, Roncon L, Caldarola P, Amodeo V, Urbinati S, Di Lenarda A, Valente S, Aspromonte N, Cipriani M, Domenicucci S, Francese GM, Imazio M, Scotto di Uccio F, Scherillo M, Di Pasquale G, Gulizia MM, Gabrielli D. Position paper ANMCO: Ruolo della Cardiologia nella gestione dei bisogni di salute in era post-COVID-19 [ANMCO Position paper: role of cardiology in the management of health needs in the post-COVID-19 era]. G Ital Cardiol (Rome). 2020;21:509–13.
pubmed: 32555566
Cammalleri V, Muscoli S, Benedetto D, Stifano G, Macrini M, Di Landro A, Di Luozzo M, Marchei M, Mariano EG, Cota L, Sergi D, Bezzeccheri A, Bonanni M, Baluci M, De Vico P, Romeo F. Who has seen patients with ST-segment-elevation myocardial infarction? First Results From Italian Real-World Coronavirus Disease 2019. J Am Heart Assoc. 2020;9:e017126.
pubmed: 32901560
pmcid: 7792389
doi: 10.1161/JAHA.120.017126
van Loon RB, Veen G, Kamp O, Baur LH, van Rossum AC. Left ventricular remodeling after acute myocardial infarction: the influence of viability and revascularization - an echocardiographic substudy of the VIAMI-trial. Trials. 2014;15:329.
pubmed: 25135364
pmcid: 4141086
doi: 10.1186/1745-6215-15-329
Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125:1043–52.
pubmed: 22371442
doi: 10.1161/CIRCULATIONAHA.111.023846
Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–5.
pubmed: 32644129
pmcid: 7349096
doi: 10.1001/jama.2020.12603
Bromage DI, Cannatà A, Rind IA, Gregorio C, Piper S, Shah AM, McDonagh TA. The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic. Eur J Heart Fail. 2020;22:978–84.
pubmed: 32478951
doi: 10.1002/ejhf.1925
Cannatà A, Bromage DI, Rind IA, Gregorio C, Bannister C, Albarjas M, Piper S, Shah AM, McDonagh TA. Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London. Eur J Heart Fail. 2020;22:2219–24.
pubmed: 32809274
doi: 10.1002/ejhf.1986
Andersson C, Gerds T, Fosbøl E, Phelps M, Andersen J, Lamberts M, Holt A, Butt JH, Madelaire C, Gislason G, Torp-Pedersen C, Køber L, Schou M. Incidence of new-onset and worsening heart failure before and after the COVID-19 epidemic lockdown in Denmark: a nationwide cohort study. Circ Heart Fail. 2020;13:e007274.
pubmed: 32482087
doi: 10.1161/CIRCHEARTFAILURE.120.007274
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;2013(62):e147-239.
doi: 10.1016/j.jacc.2013.05.019
DeFilippis EM, Reza N, Donald E, Givertz MM, Lindenfeld J, Jessup M. Considerations for heart failure care during the COVID-19 pandemic. JACC Heart Fail. 2020;8:681–91.
pubmed: 32493638
pmcid: 7266777
doi: 10.1016/j.jchf.2020.05.006
Reza N, DeFilippis EM, Jessup M. Secondary impact of the COVID-19 pandemic on patients with heart failure. Circ Heart Fail. 2020;13:e007219.
pubmed: 32352841
doi: 10.1161/CIRCHEARTFAILURE.120.007219
Centers for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19). Cent Dis Control Prev. 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-hcf.html . Accessed Feb 2021.
Karamchandani K, Quintili A, Landis T, Bose S. Cardiac arrhythmias in critically ill patients with COVID-19: a brief review. J Cardiothorac Vasc Anesth. 2020;S1053–0770(20):30807–17.
Mattioli AV, Ballerini Puviani M, Nasi M, Farinetti A. COVID-19 pandemic: the effects of quarantine on cardiovascular risk. Eur J Clin Nutr. 2020;74:852–5.
pubmed: 32371988
pmcid: 7199203
doi: 10.1038/s41430-020-0646-z
Mattioli AV, Cossarizza A, Boriani G. COVID-19 pandemic: usefulness of telemedicine in management of arrhythmias in elderly people. J Geriatr Cardiol. 2020;17:593–6.
pubmed: 33117426
pmcid: 7568046
Cannata A, Bromage DI, McDonagh T. Cardiology after COVID-19: Quo Vademus? Eur Heart J Qual Care Clin Outcomes. 2020;6:208–9.
pubmed: 32379892
doi: 10.1093/ehjqcco/qcaa042
Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, Beretta G, Reali F, Parogni P, Facchin F, Bua D, Rizzi U, Bussi D, Ruggeri S, OltronaVisconti L, Savastano S, Lombardia CARe Researchers. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy. N Engl J Med. 2020;383:496–8.
pubmed: 32348640
doi: 10.1056/NEJMc2010418
Gulizia MM, Zecchin M, Colivicchi F, Francese GM, Murrone A, Caldarola P, Di Lenarda A, Valente S, Roncon L, Amodeo E, Aspromonte N, Cipriani MG, Domenicucci S, Imazio M. Scotto Di Uccio F, Urbinati S, Gabrielli D. Position paper ANMCO: Gestione dei pazienti con sospetto o conclamato COVID-19 e necessità di procedure di elettrofisiologia e/o elettrostimolazione urgenti [ANMCO Position paper: Guidance for the management of suspected or confirmed COVID-19 patients requiring urgent electrophysiological procedures]. G Ital Cardiol. 2020;21:336–40.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;2016(37):2129–200.
doi: 10.1093/eurheartj/ehw128
The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 pandemic. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance . (Last update: 10 June 2020).
Russo V, Rago A, Carbone A, Bottino R, Ammendola E, Della Cioppa N, Galante D, Golino P, Nigro G. Atrial fibrillation in COVID-19: from epidemiological association to pharmacological implications. J Cardiovasc Pharmacol. 2020;76:138–45.
pubmed: 32453074
doi: 10.1097/FJC.0000000000000854
Michaud V, Dow P, Al Rihani SB, Deodhar M, Arwood M, Cicali B, Turgeon J. Risk assessment of drug-induced long QT syndrome for some COVID-19 repurposed drugs. Clin Transl Sci. 2021;14:20–8.
pubmed: 32888379
doi: 10.1111/cts.12882
Santoro F, Monitillo F, Raimondo P, Lopizzo A, Brindicci G, Gilio M, et al. QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry. Clin Infect Dis. 2020:ciaa1578.
Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19). Mayo Clin Proc. 2020;95:1213–21.
pubmed: 32359771
doi: 10.1016/j.mayocp.2020.03.024
Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, Cooper LT Jr, Chahal CAA. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17:1463–71.
pubmed: 32387246
pmcid: 7199677
doi: 10.1016/j.hrthm.2020.05.001
Citro R, Pontone G, Bellino M, Silverio A, Iuliano G, Baggiano A, Manka R, Iesu S, Vecchione C, Asch FM, Ghadri JR, Templin C. Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19. Trends Cardiovasc Med. 2021;31:8–16.
pubmed: 33065315
doi: 10.1016/j.tcm.2020.10.001
Agdamag ACC, Edmiston JB, Charpentier V, Chowdhury M, Fraser M, Maharaj VR, Francis GS, Alexy T. Update on COVID-19 myocarditis. Medicina. 2020;56:678.
pubmed: 33317101
pmcid: 7764165
doi: 10.3390/medicina56120678
Peretto G, De Luca G, Campochiaro C, Palmisano A, Busnardo E, Sartorelli S, Barzaghi F, Cicalese MP, Esposito A, Sala S. Telemedicine in myocarditis: evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic. Am Heart J. 2020;229:121–6.
pubmed: 32957030
pmcid: 7419248
doi: 10.1016/j.ahj.2020.07.015
Norderfeldt J, Liliequist A, Frostell C, Adding C, Agvald P, Eriksson M, et al. Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care. Acta Anaesthesiol Scand. 2021;65:761–9.
Pagnesi M, Baldetti L, Beneduce A, Calvo F, Gramegna M, Pazzanese V, Ingallina G, Napolano A, Finazzi R, Ruggeri A, Ajello S, Melisurgo G, Camici PG, Scarpellini P, Tresoldi M, Landoni G, Ciceri F, Scandroglio AM, Agricola E, Cappelletti AM. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart. 2020;106:1324–31.
pubmed: 32675217
doi: 10.1136/heartjnl-2020-317355
Suzuki YJ, Nikolaienko SI, Shults NV, Gychka SG. COVID-19 patients may become predisposed to pulmonary arterial hypertension. Med Hypotheses. 2021;147:110483.
pubmed: 33444904
pmcid: 7787059
doi: 10.1016/j.mehy.2021.110483
Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, Kurz K, Koppelstätter S, Haschka D, Petzer V, Boehm A, Aichner M, Tymoszuk P, Lener D, Theurl M, Lorsbach-Köhler A, Tancevski A, Schapfl A, Schaber M, Hilbe R, Nairz M, Puchner B, Hüttenberger D, Tschurtschenthaler C, Aßhoff M, Peer A, Hartig F, Bellmann R, Joannidis M, Gollmann-Tepeköylü C, Holfeld J, Feuchtner G, Egger A, Hoermann G, Schroll A, Fritsche G, Wildner S, Bellmann-Weiler R, Kirchmair R, Helbok R, Prosch H, Rieder D, Trajanoski Z, Kronenberg F, Wöll E, Weiss G, Widmann G, Löffler-Ragg J, Tancevski I. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57:2003481.
pubmed: 33303539
pmcid: 7736754
doi: 10.1183/13993003.03481-2020
Tudoran C, Tudoran M, Lazureanu VE, Marinescu AR, Pop GN, Pescariu AS, Enache A, Cut TG. Evidence of pulmonary hypertension after SARS-CoV-2 infection in subjects without previous significant cardiovascular pathology. J Clin Med. 2021;10:199.
pubmed: 33430492
pmcid: 7827420
doi: 10.3390/jcm10020199
Atabati E, Dehghani-Samani A, Mortazavimoghaddam SG. Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: a narrative review. Can J Respir Ther. 2020;56:1–9.
pubmed: 33274259
pmcid: 7690312
van Dongen CM, Janssen MT, van der Horst RP, van Kraaij DJ, Peeters RH, van den Toorn LM, Mostard RL. Unusually rapid development of pulmonary hypertension and right ventricular failure after COVID-19 pneumonia. Eur J Case Rep Intern Med. 2020;7:001784.
pubmed: 32665939
pmcid: 7350962
Mishra A, Lal A, Sahu KK, George AA, Martin K, Sargent J. An update on pulmonary hypertension in coronavirus disease-19 (COVID-19). Acta Biomed. 2020;91:e2020155.
pubmed: 33525228
pmcid: 7927547
Martini N, Piccinni C, Pedrini A, Maggioni A. Covid-19 e malattie croniche: conoscenze attuali, passi futuri e il progetto MaCroScopio [Covid-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]. Recenti Prog Med. 2020;111:198–201.
pubmed: 32319439
Correale M, Paolillo S, Mercurio V, Limongelli G, Barillà F, Ruocco G, Palazzuoli A, Scrutinio D, Lagioia R, Lombardi C, Lupi L, Magrì D, Masarone D, Pacileo G, Scicchitano P, Matteo Ciccone M, Parati G, Tocchetti CG, Nodari S. Comorbidities in chronic heart failure: an update from Italian Society of Cardiology (SIC) Working Group on Heart Failure. Eur J Intern Med. 2020;71:23–31.
pubmed: 31708358
doi: 10.1016/j.ejim.2019.10.008
Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020;21:1470320320926899.
pubmed: 32408793
pmcid: 7231906
doi: 10.1177/1470320320926899
Itoh H. A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension. Hypertens Res. 2020;43:857–8.
pubmed: 32555413
pmcid: 7301354
doi: 10.1038/s41440-020-0497-y
Kario K, Nishizawa M, Hoshide S, Shimpo M, Ishibashi Y, Kunii O, et al. Development of a disaster cardiovascular prevention network. Lancet. 2011;378:1125–7.
pubmed: 21885110
doi: 10.1016/S0140-6736(11)61187-2
Kant S, Menez SP, Hanouneh M, Fine DM, Crews DC, Brennan DC, Sperati CJ, Jaar BG. The COVID-19 nephrology compendium: AKI, CKD ESKD and transplantation. BMC Nephrol. 2020;21:449.
pubmed: 33109103
pmcid: 7590240
doi: 10.1186/s12882-020-02112-0
Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X. Zhang C Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Rene Int. 2020;98:219–27.
Wang L, Li X, Chen H, Yan S, Li D, Li Y, Gong Z. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan. China Am J Nephrol. 2020;51:343–8.
pubmed: 32229732
doi: 10.1159/000507471
Ulu S, Gungor O. Ebru Gok Oguz, Nuri Baris Hasbal, Didem Turgut, and Mustafa Arici COVID-19: a novel menace for the practice of nephrology and how to manage it with minor devastation? Ren Fail. 2020;42:710–25.
pubmed: 32713282
pmcid: 7470161
doi: 10.1080/0886022X.2020.1797791
Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. J Med Virol. 2020;93:1387–95.
Valente S, Colivicchi F, Francese MG, Di Lenarda A, Roncon L, Murrone A, Caldarola P, Bilato C, Amodeo E, Aspromonte N, Cipriani M, Domenicucci S, Imazio M. Scotto di Uccio F, Urbinati S, Gulizia MM, Gabrielli D. Position paper ANMCO: Le attività ambulatoriali cardiologiche nella fase di transizione della pandemia COVID-19 [ANMCO Position paper: Cardiological outpatient activities in the transition phase of the COVID-19 pandemic]. G Ital Cardiol. 2020;21:584–8.
Ong EHM. War on SARS: a Singapore experience. Can J Emerg Med. 2004;6:31–7.
doi: 10.1017/S1481803500008873
Nadarajan GD, Omar E, Abella BS, Hoe PS, Do Shin S, Ma MH, Ong MEH. A conceptual framework for Emergency department design in a pandemic. Scand J Trauma Resusc Emerg Med. 2020;28:118.
pubmed: 33334364
pmcid: 7745175
doi: 10.1186/s13049-020-00809-7
Huber K, Goldstein P. Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2020;9:222–8.
pubmed: 32375487
doi: 10.1177/2048872620923639
Her M. Repurposing and reshaping of hospitals during the COVID-19 outbreak in South Korea. One Health. 2020;10:100137.
pubmed: 32373705
pmcid: 7198431
doi: 10.1016/j.onehlt.2020.100137
Chung HS, Lee DE, Kim JK, Yeo IH, Kim C, Park J, Seo KS, Park SY, Kim JH, Kim G, Lee SH, Cheon JJ, Kim YH. Revised triage and surveillance protocols for temporary emergency department closures in tertiary hospitals as a response to COVID-19 crisis in Daegu Metropolitan City. J Korean Med Sci. 2020;35:e189.
pubmed: 32419401
pmcid: 7234857
doi: 10.3346/jkms.2020.35.e189
Yaddanapudi S. Ensuring adequate healthcare in COVID and non-COVID areas: an unprecedented challenge. J Anaesthesiol Clin Pharmacol. 2020;36(Suppl 1):S6–7.
pubmed: 33100638
pmcid: 7573997
doi: 10.4103/joacp.JOACP_296_20
Nacoti M, Ciocca A, Giupponi A, Brambillasca P, Lussana F, Pisano M, et al. At the epicenter of the COVID-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catalyst. 2020. https://doi.org/10.1056/CAT.20.0080 .
Bilato C, Roncon L, Anselmi M, Valle R, Perrone C, Mecenero A, Zuin M. Themistoclakis S; a nome dell’ANMCO Veneto. La gestione del paziente cardiologico nella fase post-pandemia COVID-19: la proposta dell’ANMCO Regionale Veneto [Managing cardiac patients post-COVID-19 pandemic: a proposal by the ANMCO Veneto Region]. G Ital Cardiol. 2020;21:408–16.
Scotto Di Uccio F, Valente S, Colivicchi F, Murrone A, Caldarola P, Di Lenarda A, Roncon L, Amodeo E, Aspromonte N, Cipriani MG, Domenicucci S, Francese GM, Imazio M, Urbinati S, Gulizia MM, Gabrielli D. Position paper ANMCO: Organizzazione della Rete per il trattamento dei pazienti con sindrome coronarica acuta durante emergenza pandemica COVID-19 [ANMCO Position paper: The network organization for the management of patients with acute coronary syndrome during the COVID-19 pandemic]. G Ital Cardiol. 2020;21:332–5.
Valente S, Colivicchi F, Caldarola P, Murrone A, Di Lenarda A, Roncon L, Amodeo E, Aspromonte N, Cipriani MG, Domenicucci S, Francese GM, Imazio M. Scotto Di Uccio F, Urbinati S, Gulizia MM, Gabrielli D. Position paper ANMCO: Gestione delle consulenze e attività ambulatoriali cardiologiche in corso di pandemia COVID-19 [ANMCO Position paper: Considerations on in-hospital cardiological consultations and cardiology outpatient clinics during the COVID-19 pandemic]. G Ital Cardiol. 2020;21:341–4.
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, BanningBenedetto APU, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, ESC Scientific Document Group. ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018;2019(40):87–165.
Ibánez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol. 2017;70:1082.
pubmed: 29198432
Charman SJ, Velicki L, Okwose NC, Harwood A, McGregor G, Ristic A, et al. Insights into heart failure hospitalizations, management, and services during and beyond COVID-19. ESC Heart Fail. 2020;8:175–82.
De Filippo O, D’Ascenzo F, De Ferrari GM. Heart failure-related hospitalisation and management during the COVID-19 pandemic: a reflection. Reply. Eur J Heart Fail. 2020;23:344.
Shah N, Ahmed I, Nazir T. Heart failure-related hospitalisation and management during the COVID-19 pandemic: a reflection. Eur J Heart Fail. 2020;23:343–4.
Salzano A, D’Assante R, Stagnaro FM, Valente V, Crisci G, Giardino F, Arcopinto M, Bossone E, Marra AM, Cittadini A. Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre. Eur J Heart Fail. 2020;22:1048–50.
pubmed: 32463534
doi: 10.1002/ejhf.1911
Murrone A, Colivicchi F, Roncon L, Caldarola P, Amodeo V, Urbinati S, Di Lenarda A, Valente S, Aspromonte N, Cipriani M, Domenicucci S, Francese GM, Imazio M. Scotto di Uccio F, Scherillo M, Di Pasquale G, Gulizia MM, Gabrielli D. Position paper ANMCO: Ruolo della Cardiologia nella gestione dei bisogni di salute in era post-COVID-19 [ANMCO Position paper: Role of cardiology in the management of health needs in the post-COVID-19 era]. G Ital Cardiol. 2020;21:509–13.
D’Amario D, Restivo A, Canonico F, Rodolico D, Galli M, Burzotta F, Vergallo R, Trani C, Aspromonte N, Crea F. Experience of remote cardiac care during Covid.19 pandemic: the V.LAP
pubmed: 32431021
doi: 10.1002/ejhf.1900
Walsh MN, Ravichandran AK, Seasor E, Salerno CT. Clinical distancing of hospitalized patients with advanced heart failure and cardiac transplantation during COVID.19. J Heart Lung Transplant. 2020;39:730.
pubmed: 32505491
pmcid: 7211686
doi: 10.1016/j.healun.2020.04.024
Agostoni P, Mapelli M, Conte E, Baggiano A, Assanelli E, Apostolo A, Alimento M, Berna G, Guglielmo M, Muratori M, Susini F, Palermo P, Pezzuto B, Salvioni E, Sudati A, Vignati C, Merlino L. Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID.19. Eur J Prev Cardiol. 2020;27:1127–32.
pubmed: 32418489
pmcid: 7717250
doi: 10.1177/2047487320925632